Vantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US)

NCT ID: NCT05691868

Last Updated: 2025-02-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

400 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-08

Study Completion Date

2031-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study are to evaluate the performance and safety of the Vantage Mobile-Bearing Total Angle System. This study will follow subjects for a period of up to 10 years post-surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis Arthritis of Ankle Failure, Prosthesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is indicated for total ankle arthroplasty
* Patient is at least 21 years of age
* Patient is likely to be available for follow-up out to 10 years
* Patient is willing to participate by complying with pre- and postoperative visit requirements
* Patient is willing and able to read and sign a study informed consent form

Exclusion Criteria

* Patient with excessive bone loss at the ankle joint site
* Patient with severe osteoporosis
* Patient with complete talar avascular necrosis
* Patient with active osteomyelitis
* Patient with infection at the ankle site or infection at distant sites that could migrate to the ankle
* Patient with sepsis
* Patient with vascular deficiency in the involved limb
* Pateint with neuropathic joints
* Patient with neurological or musculoskeletal disease or loss of function that may adversely affect movement of the lower limb, gait, or weight bearing
* Patient with poor soft tissue coverage around the ankle
* Patient with Charcot arthropathy
* Previsous ankle arthrodesis with excision of the malleoli
* Excessive loads as cuased by activity or patient weight - per investigator discretion
* Skeletally immature patients (patient is less than 21 years if age at time of surgery)
* Patient with dementia
* Patient with known metal allergies
* Patients who are unwilling to provide informed consent
* Patients who are unlikely to be available for follow-up out to 10 years
* Patients who are not deemed suitable candidates for the subject device
* Patient is pregnant
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Exactech

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Victor Valderrabano, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

SWISS ORTHO CENTER Pain Clinic Basel

Mario Herrera- Perez, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitario de Canarias

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitario de Canarias

Santa Cruz de Tenerife, , Spain

Site Status RECRUITING

SWISS ORTHO CENTER Pain Clinic Basel

Basel, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rachael Craig

Role: CONTACT

352-377-1140

Sandrine Angibaud

Role: CONTACT

352-377-1140

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alejandro Herrera

Role: primary

+ 0034 922678500

Victor Valderrabano

Role: primary

+41 61 295 88 80

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CR16-004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Perform Humeral System Study
NCT05067543 RECRUITING
The 3DKnee™ System: A Post-Market Study
NCT00764673 COMPLETED PHASE4
Vanguard Rocc Post Market Surveillance
NCT03664791 ACTIVE_NOT_RECRUITING
AEQUALIS™ FLEX REVIVE™ Study (REVIVE)
NCT05500066 ENROLLING_BY_INVITATION
Pyrocarbon Interposition Arthroplasty of the Elbow
NCT05464459 ACTIVE_NOT_RECRUITING NA